Authorities in Jiangsu, China, granted Zhejiang Hisun Pharmaceutical (SHA:600267) subsidiary Hisun Pharmaceutical Nantong a good manufacturing practice certification, according to a Thursday filing with the Shanghai bourse.
The inspection covered the minocycline hydrochloride production lines, it said.
Minocycline hydrochloride is an antibiotic indicated for use against Staphylococcus, Streptococcus, Pneumococcus, Neisseria gonorrhea, Shigella, Escherichia coli, Klebsiella, Proteus, Pseudomonas aeruginosa, Treponema pallidum, and Chlamydia, the filing said.
It is used to treat acne vulgaris, according to the Mayo Clinic.
Comments